Percutaneous left ventricular assist devices (LVAD) are sometimes needed for ablation procedures in unstable patients \[[@bib1]\]. However use of 3D navigation systems may be difficult or sometimes impossible in patients with percutaneous LVAD because of the major electromagnetical interferences created by the turbine of the device, leading to potential major issues with available 3D systems based on magnetic localization [@bib2]. To date, feasibility of mapping with the Rhythmia **™** system in patients implanted with an Impella has been shown to be non feasible [@bib3].Fig. 1Activation map during fast ventricular tachycardia (240 msec cycle length) showing reentrant circuit through two gaps inside the previous line of encircling lesions (black dots). The activation was recorded by the Orion **™** catheter (designed as a Constellation **™** catheter for allowing impedance-based localization) and projected on the anatomical map previously acquired while the Impella **™** was turned off. More than 18000 EGMs could be collected during 9 minutes of mapping without interference with the device.Fig. 1

We relate how to fix technical issues during ablation using the Rhythmia **™** system in a 51 year-old man with recent myocardial infarction and dilated left ventricle (EF \< 20%) with subnormal right ventricular function (TAPSE 16 mm). Because of recurring ventricular fibrillation despite anti-arrhythmic drugs, he had been equiped with an Impella CP **™** (Abiomed Inc., Danvers, MA, USA) in bridge to recovery/destination LVAD or transplantation, using an axillary artery approach due to severe peripheral artery disease.

Calibration of the Rhythmia **™** cutaneous back patch could only be done after the Impella **™** was transiently switched off. We then performed a first electro-anatomical map during ventricular pacing with the Orion **™** catheter during sequences of 3 minutes turning off separated by 3 minutes periods turning on the Impella **™**. Once the anatomical map acquired and the impedance field created, we could use the impedance-based localization for the Orion **™** catheter (designed as a Constellation **™** catheter for the system to localize it) and could freely perform full mapping of a very fast ventricular tachycardia while the Impella **™** was consistantly on ([Fig. 1](#fig1){ref-type="fig"}).

This report highlights how to deal with electromagnetical fields created by an Impella **™** device for performing ablation with the Rhythmia **™** system. If this technique allows high quality 3D mapping with other Impella **™** models or with 3D systems remains to be determined.
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